Established in April 2003, BIONIME is specialized in the business of biotechnology and medical testing. The first product line is the Self Monitoring Blood Glucose (SMBG) System. BIONIME integrates the top-tier expertise in medical science, chemistry, electronics and precision mechanism to commercialize the patented technology of unique test strip structure.
Today, BIONIME operates 4 subsidiaries in major markets, Europe, America, and China. Our products have been highly recognized by outstanding clinical tests and well-known journals internationally and successfully distributed in the worldwide markets. With the support from our customers, we are confident to grow BIONIME the global competitive leadership in the field of SMBG (Self-Monitor Blood Glucose).
With our “peace of mind“ medical devices, we offer solutions to patients to accurately manage and control their own health.
Better health for more people
Our philosophy is to provide best quality products to people in need and their care givers, so that they can easily manage their daily health. With this idea in mind, Bionime successfully integrated different technologies, combining Swiss designs and made-in-Taiwan quality assurance to continuously provide world class diagnostic solutions to our customers around the world.The unique product design and accurate and precise testing results brings even better user experiences and builds up customer satisfaction and trust, fulfilling better health for more people. Bionime will do its best to implement this philosophy to ensure your health and living quality.
Corporate MilestonesBIONIME together with qualified experts in the field of diabetes have initiated and completed several SMBG patents during the last few years. Nevertheless, innovation and creativity will continue to characterize BIONIME’s efforts in the SMBG field.
- Certified by Brazil's National Health Surveillance Agency and received ANVISA Certificate
- Successfully obtained Good Manufacturing Practices (GMP) Certification from SGS for additional products including Uric acid and Cholesterol Detection detections.
- Received capital injection by private placement of Dongbao Pharmaceutical Co., Ltd.
- Obtained new patent in China is regarding "Insulin measuring pen with biological sensors".
- Established subsidiary in Pingtan, China
- Received new patent in Germany for “Measuring Device for an Analyte”.
- Members of the Diplomatic and Economic Representatives in Taiwan Visit Bionime for Exchange International Business and Bionime’s Competitive Advantages
- GM720 won the Taiwan Excellence Award
- GM720 won the National Industrial Innovation Award
- GD500 won National Invention and Creation Award
- Pass Taiwan GMP certification
- Mylife Unio Won Reddot Design Award
- New Building & Factory completion
- New Product “Mylife Unio” shipped to European Market
- GE Selects Bionime to Launch Innovative Diabetes Solutions
- Bionime acquires the Innovation Award from Taiwan Ministry Economic Affair.
- BIONIME has passed certification of OHSAS18001.
- Acquisition land property for extending operation
- Pass Taiwan AEO Certification
- Strategic global cooperation with GE during term of Licensing Agreement in diabetes technology.
- Become a public company and traded officially as a hi-tech company on the TWSE.
- Granted the highest award of Taipei Biotech competition.
- Approved to apply a high-tech list company by Industrial Development Bureau, Ministry of Economic Affairs.
- Set up Bionime Australia Pty Limited.
- Granted SFDA of RightestGM100, 110.
- Launch of Rightest GM550 in Europe.
- Pass KGMP audit.
- Listed on Emerging Stock Market (#4737)
- In strategic alliance with Ypsomed, a Switzerland-based solution provider of injection system for diabetes treatment.
- Granted FDA 510(K) of Rightest GM100, 110.
- First shipment of ODM products.
- Launch new Lancing Device to the market.
- Set up BIONIME USA Corporation.
- Passed ISO 13845 and CMDCAS audit.
- Passed TNO Certification.
- Launch Rightest GM100.
- Set up BIONIME (ShenZhen) Co., Ltd.
- Granted China SFDA of Rightest GM300 Aug.
- Passed Taiwan GMP Certification Jun.
- Launch Rightest GM300
- Set up BIONIME GmbH Switzerland in Apr.
- Granted FDA 510(K) of Rightest GM300.
- Set up BIONIME INCORPORATED Dec.
- Granted CE Certification and passed ISO13485 Certification.
- The development of the first generation of blood glucose meter was completed.
- BIONIME was founded at Dali City, Taichung County Apr.
Bionime Corporation, Headquarters
FAX: +886 4 2261 7586
Address: No.100, Sec. 2, Daqing St., South Dist., Taichung City 40242, Taiwan (R.O.C.)
Service Hours: Monday ~ Friday 8:30 am - 5:30 pm
Toll-Free: 0800 371 688
Bionime GmbH (Switzerland)
FAX: +41 71 722 9843
Address: Tramstrasse 16, 9442 Berneck, Switzerland
Bionime USA Corporation
FAX: +1 909 781 6970
Address: 1450 E Spruce Street, Bldg. B, Ontario CA 91761-8314
Bionime (Pingtan) Co., Ltd.
FAX: +86 591 6252 3166
Address: Taiwan Pioneer Park, Pingtan Comprehensive Experimental Area, Pingtan County, Fuzhou City, Fujian Province, China
FAX: +86 21 6208 3537
Address: Room 501, No. 567, Tian Yao Qiao Road, Xuhui District, Shanghai City, China